Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Clinical trial NCT04755868 · UNKNOWN

Trial details

NCT number: NCT04755868
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2021-03-01
Primary completion: 2024-03-01
Enrollment: 206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.